|
Pivotal studies indicate a role of excision repair cross-complementation 1 (ERCC1) gene and ribonucleotide reductase M1 (RRM1) gene in conferring a differential sensitivity to cytotoxic chemotherapy and epidermal growth factor receptor (EGFR) gene has been recently extensively investigated in non-small-cell lung cancer (NSCLC).
Sponsored Links:
|
| URL: |
http://www.clarientinc.com/
|
| Title: |
Clarient InsightDx® Mammostrat |
| Image: |
 |
| Description: |
Mammostrat is a novel test for estimating the risk for recurrence in hormone-receptor positive, early stage breast cancer that is independent of proliferation and grade. Five biomarkers are combined with a defined mathematical algorithm resulting in a risk index. |
| Category: |
Egfr
-
Cancer Diagnostics Company
-
Cancer Diagnostic Services Pi3k
-
Eml4-alk
-
Braf
-
Kras
-
Pulmotype
-
Independent Of Proliferation And Grade
|